Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura A. Lucaciu"'
Autor:
Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones, Charles W. Lees
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background and aims: Tofacitinib is a Janus kinase inhibitor (JAKi) recently approved for the treatment of moderate to severe ulcerative colitis (UC) based on robust efficacy and safety data derived from OCTAVE clinical trials. Evidence on the outcom
Externí odkaz:
https://doaj.org/article/0d603ef9e2ef4abfa25ca31213ebca59
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:669-677
In the 'treat-to-target' era of inflammatory bowel disease (IBD) management, small molecule drugs (SMDs) represent a promising alternative to biomolecular drugs. Moreover, increasing failure rates of anti-tumor necrosis factor α agents have contribu
Autor:
Cristina Adela Iuga, Radu Seicean, Laura A. Lucaciu, Ștefan C. Vesa, Maria Ilieș, Andrada Seicean, Shahida Din
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 11
Lucaciu, L A, Ilieș, M, Vesa, Ș C, Seicean, R, Din, S, Iuga, C A & Seicean, A 2021, ' Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease ', Journal of personalized medicine, vol. 11, no. 11, pp. 1130 . https://doi.org/10.3390/jpm11111130
Journal of Personalized Medicine, Vol 11, Iss 1130, p 1130 (2021)
Volume 11
Issue 11
Lucaciu, L A, Ilieș, M, Vesa, Ș C, Seicean, R, Din, S, Iuga, C A & Seicean, A 2021, ' Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease ', Journal of personalized medicine, vol. 11, no. 11, pp. 1130 . https://doi.org/10.3390/jpm11111130
Journal of Personalized Medicine, Vol 11, Iss 1130, p 1130 (2021)
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We assessed the relevancy of IL-17 and IL-23 serum levels as potential biomarkers towar
Autor:
Sorana D. Bolboacă, Vasile Sandru, Ofelia Mostean, Mihai Rimbas, Adrian Bartos, Nadim Al Hajjar, Gabriel Constantinescu, Laura A. Lucaciu, Cristina Pojoga, Andrada Seicean, Madalina Ilie, Radu Seicean, Marcel Gheorghiu
Publikováno v:
Journal of gastrointestinal and liver diseases : JGLD. 29(4)
Background and Aims: The fully-covered, lumen apposing metal stents are designed for one step placement, facilitating the direct endoscopic necrosectomy into the walled-off pancreatic necrosis. However, the prediction of the number of necrosectomy se
Autor:
N Al Hajjar, Ofelia Mosteanu, Adrian Bartos, Andrada Seicean, Marcel Gheorghiu, Laura A. Lucaciu, Cristina Pojoga, Radu Seicean
Publikováno v:
ESGE Days.
Autor:
Laura A, Lucaciu, Dan L, Dumitrascu
Publikováno v:
Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Interferon-based therapies were until recently the standard of care in chronic hepatitis C (CHC), despite their side effects. We aimed to review the available data on the depression and suicide in CHC patients receiving or not antiviral therapy based